BioCentury | Nov 30, 2017
Company News

Management Tracks:Sunesis, City of Hope

...as CFO and SVP of finance and corporate development. He was president and CEO of Bullet Biotechnology Inc....
BioCentury | Mar 24, 2014
Emerging Company Profile

Bullet: Idiotype builder

...Park, Calif. Aragen Bioscience Inc. , Morgan Hill, Calif. Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Bullet Biotechnology Inc....
...NYSE:JNJ), New Brunswick, N.J. Pharmacyclics Inc. (NASDAQ:PCYC), Sunnyvale, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sidebars Bullet Biotechnology Inc....
BioCentury | Sep 30, 2013
Clinical News

Bullet Biotechnology preclinical data

...is a personalized active immunotherapy consisting of the idiotype protein on B cell lymphoma cells. Bullet Biotechnology Inc....
BioCentury | Sep 16, 2013
Financial News

Bullet Biotechnology completes venture financing

...Business: Cancer Date completed: 6/1/13 Type: Venture financing Raised: $2.5 million Note: On Sept. 12, Bullet Biotechnology...
BioCentury | Jul 29, 2013
Financial News

Bullet Biotechnology completes venture financing

...Date completed: 7/9/13 Type: Venture financing Raised: $1.1 million Note: According to an SEC filing, Bullet Biotechnology...
Items per page:
1 - 5 of 5
BioCentury | Nov 30, 2017
Company News

Management Tracks:Sunesis, City of Hope

...as CFO and SVP of finance and corporate development. He was president and CEO of Bullet Biotechnology Inc....
BioCentury | Mar 24, 2014
Emerging Company Profile

Bullet: Idiotype builder

...Park, Calif. Aragen Bioscience Inc. , Morgan Hill, Calif. Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Bullet Biotechnology Inc....
...NYSE:JNJ), New Brunswick, N.J. Pharmacyclics Inc. (NASDAQ:PCYC), Sunnyvale, Calif. Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Sidebars Bullet Biotechnology Inc....
BioCentury | Sep 30, 2013
Clinical News

Bullet Biotechnology preclinical data

...is a personalized active immunotherapy consisting of the idiotype protein on B cell lymphoma cells. Bullet Biotechnology Inc....
BioCentury | Sep 16, 2013
Financial News

Bullet Biotechnology completes venture financing

...Business: Cancer Date completed: 6/1/13 Type: Venture financing Raised: $2.5 million Note: On Sept. 12, Bullet Biotechnology...
BioCentury | Jul 29, 2013
Financial News

Bullet Biotechnology completes venture financing

...Date completed: 7/9/13 Type: Venture financing Raised: $1.1 million Note: According to an SEC filing, Bullet Biotechnology...
Items per page:
1 - 5 of 5